Intent to Build Hepatitis C Treatment Capacity Within Family Medicine Residencies: A Nationwide Survey of Program Directors: A CERA Study

Camille Webb Camminati, Aditya Simha, N. Randall Kolb, Ramakrishna Prasad

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

BACKGROUND AND OBJECTIVES: In the current interferon-free era, family medicine is in a unique position to deliver hepatitis C (HCV) treatment with adequate training. Little is known about attitudes of family medicine program directors (PDs) toward capacity building within their residency programs. We report the results of a nationwide survey of family medicine PDs to examine these attitudes.

METHODS: This study was part of a CERA (Council of Academic Family Medicine Educational Research Alliance) omnibus survey administered to family medicine PDs between February 2015 and March 2015. Attitudes were assessed using a Likert scale ranging from 1=strongly disagree to 6=strongly agree.

RESULTS: We surveyed 452 physicians, with 273 responses (response rate 61%). The majority of PDs (78%) believed that chronic HCV represented a significant problem for primary care, and 61.9% believed their program should take steps to build capacity in HCV treatment. There was no effect of regional HCV prevalence, residency program context, or PD characteristics on intent to build capacity.

CONCLUSIONS: This is the first report to examine PDs intent to build capacity in HCV treatment in this interferon-free, direct antiviral era. Our findings highlight a historic opportunity to train family physicians and position them on the frontline as HCV treatment providers.

Original languageEnglish (US)
Pages (from-to)631-634
Number of pages4
JournalFamily medicine
Volume48
Issue number8
StatePublished - Sep 1 2016
Externally publishedYes

Fingerprint

Hepatitis C
Internship and Residency
Medicine
Interferons
Capacity Building
Therapeutics
Family Physicians
Antiviral Agents
Primary Health Care
Surveys and Questionnaires
Physicians
Research

ASJC Scopus subject areas

  • Family Practice

Cite this

Intent to Build Hepatitis C Treatment Capacity Within Family Medicine Residencies : A Nationwide Survey of Program Directors: A CERA Study. / Webb Camminati, Camille; Simha, Aditya; Kolb, N. Randall; Prasad, Ramakrishna.

In: Family medicine, Vol. 48, No. 8, 01.09.2016, p. 631-634.

Research output: Contribution to journalArticle

Webb Camminati, Camille ; Simha, Aditya ; Kolb, N. Randall ; Prasad, Ramakrishna. / Intent to Build Hepatitis C Treatment Capacity Within Family Medicine Residencies : A Nationwide Survey of Program Directors: A CERA Study. In: Family medicine. 2016 ; Vol. 48, No. 8. pp. 631-634.
@article{9a8e1a1c67bb4b46bb94935d5a347f22,
title = "Intent to Build Hepatitis C Treatment Capacity Within Family Medicine Residencies: A Nationwide Survey of Program Directors: A CERA Study",
abstract = "BACKGROUND AND OBJECTIVES: In the current interferon-free era, family medicine is in a unique position to deliver hepatitis C (HCV) treatment with adequate training. Little is known about attitudes of family medicine program directors (PDs) toward capacity building within their residency programs. We report the results of a nationwide survey of family medicine PDs to examine these attitudes.METHODS: This study was part of a CERA (Council of Academic Family Medicine Educational Research Alliance) omnibus survey administered to family medicine PDs between February 2015 and March 2015. Attitudes were assessed using a Likert scale ranging from 1=strongly disagree to 6=strongly agree.RESULTS: We surveyed 452 physicians, with 273 responses (response rate 61{\%}). The majority of PDs (78{\%}) believed that chronic HCV represented a significant problem for primary care, and 61.9{\%} believed their program should take steps to build capacity in HCV treatment. There was no effect of regional HCV prevalence, residency program context, or PD characteristics on intent to build capacity.CONCLUSIONS: This is the first report to examine PDs intent to build capacity in HCV treatment in this interferon-free, direct antiviral era. Our findings highlight a historic opportunity to train family physicians and position them on the frontline as HCV treatment providers.",
author = "{Webb Camminati}, Camille and Aditya Simha and Kolb, {N. Randall} and Ramakrishna Prasad",
year = "2016",
month = "9",
day = "1",
language = "English (US)",
volume = "48",
pages = "631--634",
journal = "Family Medicine",
issn = "0742-3225",
publisher = "Society of Teachers of Family Medicine",
number = "8",

}

TY - JOUR

T1 - Intent to Build Hepatitis C Treatment Capacity Within Family Medicine Residencies

T2 - A Nationwide Survey of Program Directors: A CERA Study

AU - Webb Camminati, Camille

AU - Simha, Aditya

AU - Kolb, N. Randall

AU - Prasad, Ramakrishna

PY - 2016/9/1

Y1 - 2016/9/1

N2 - BACKGROUND AND OBJECTIVES: In the current interferon-free era, family medicine is in a unique position to deliver hepatitis C (HCV) treatment with adequate training. Little is known about attitudes of family medicine program directors (PDs) toward capacity building within their residency programs. We report the results of a nationwide survey of family medicine PDs to examine these attitudes.METHODS: This study was part of a CERA (Council of Academic Family Medicine Educational Research Alliance) omnibus survey administered to family medicine PDs between February 2015 and March 2015. Attitudes were assessed using a Likert scale ranging from 1=strongly disagree to 6=strongly agree.RESULTS: We surveyed 452 physicians, with 273 responses (response rate 61%). The majority of PDs (78%) believed that chronic HCV represented a significant problem for primary care, and 61.9% believed their program should take steps to build capacity in HCV treatment. There was no effect of regional HCV prevalence, residency program context, or PD characteristics on intent to build capacity.CONCLUSIONS: This is the first report to examine PDs intent to build capacity in HCV treatment in this interferon-free, direct antiviral era. Our findings highlight a historic opportunity to train family physicians and position them on the frontline as HCV treatment providers.

AB - BACKGROUND AND OBJECTIVES: In the current interferon-free era, family medicine is in a unique position to deliver hepatitis C (HCV) treatment with adequate training. Little is known about attitudes of family medicine program directors (PDs) toward capacity building within their residency programs. We report the results of a nationwide survey of family medicine PDs to examine these attitudes.METHODS: This study was part of a CERA (Council of Academic Family Medicine Educational Research Alliance) omnibus survey administered to family medicine PDs between February 2015 and March 2015. Attitudes were assessed using a Likert scale ranging from 1=strongly disagree to 6=strongly agree.RESULTS: We surveyed 452 physicians, with 273 responses (response rate 61%). The majority of PDs (78%) believed that chronic HCV represented a significant problem for primary care, and 61.9% believed their program should take steps to build capacity in HCV treatment. There was no effect of regional HCV prevalence, residency program context, or PD characteristics on intent to build capacity.CONCLUSIONS: This is the first report to examine PDs intent to build capacity in HCV treatment in this interferon-free, direct antiviral era. Our findings highlight a historic opportunity to train family physicians and position them on the frontline as HCV treatment providers.

UR - http://www.scopus.com/inward/record.url?scp=85024368015&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024368015&partnerID=8YFLogxK

M3 - Article

C2 - 27655196

AN - SCOPUS:85024368015

VL - 48

SP - 631

EP - 634

JO - Family Medicine

JF - Family Medicine

SN - 0742-3225

IS - 8

ER -